|
PSMD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.756800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.226600E-01 |
| Normal-vs-Stage2 |
9.373600E-01 |
| Normal-vs-Stage3 |
7.789600E-01 |
| Normal-vs-Stage4 |
2.829200E-01 |
| Stage1-vs-Stage2 |
7.183000E-01 |
| Stage1-vs-Stage3 |
4.624600E-01 |
| Stage1-vs-Stage4 |
1.421790E-01 |
| Stage2-vs-Stage3 |
8.812000E-01 |
| Stage2-vs-Stage4 |
4.270600E-01 |
| Stage3-vs-Stage4 |
3.747200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.225600E-01 |
| Normal-vs-AfricanAmerican |
1.311970E-01 |
| Normal-vs-Asian |
9.588200E-01 |
| Caucasian-vs-AfricanAmerican |
1.199430E-01 |
| Caucasian-vs-Asian |
8.892400E-01 |
| AfricanAmerican-vs-Asian |
2.582600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.739000E-01 |
| Normal-vs-Female |
7.855200E-01 |
| Male-vs-Female |
2.075600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.617000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.239600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.494800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.239800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.957600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.319400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.893600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.636800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.445600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.527800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.673200E-01 |
| Classical-VS-Follicular |
7.019400E-03 |
| Classical-VS-Other |
2.537900E-02 |
| Classical-VS-Normal |
3.448400E-01 |
| Tall-VS-Follicular |
2.920200E-01 |
| Tall-VS-Other |
9.287600E-02 |
| Tall-VS-Normal |
9.835200E-01 |
| Follicular-VS-Other |
3.624000E-01 |
| Follicular-VS-Normal |
1.561620E-01 |
| Other-VS-Normal |
5.565700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.366000E-01 |
| Normal-vs-N1 |
1.680210E-01 |
| N0-vs-N1 |
2.804800E-01 |
|
|
